BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36120473)

  • 1. Potential biomarkers for clinical outcomes of IVF cycles in women with/without PCOS: Searching with metabolomics.
    Guan SY; Liu YY; Guo Y; Shen XX; Liu Y; Jin HX
    Front Endocrinol (Lausanne); 2022; 13():982200. PubMed ID: 36120473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.
    Lu XE; Huang HF; Li MG; Zhu YM; Qiang YL; Dong MY
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):897-902. PubMed ID: 16130192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukaemia inhibitory factor in serum and follicular fluid of women with polycystic ovary syndrome and its correlation with IVF outcome.
    Li Z; Zhu Y; Li H; Jiang W; Liu H; Yan J; Chen ZJ; Li W
    Reprod Biomed Online; 2018 Apr; 36(4):483-489. PubMed ID: 29397316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular fluid lipidomic profiling reveals potential biomarkers of polycystic ovary syndrome: A pilot study.
    Ding Y; Jiang Y; Zhu M; Zhu Q; He Y; Lu Y; Wang Y; Qi J; Feng Y; Huang R; Yin H; Li S; Sun Y
    Front Endocrinol (Lausanne); 2022; 13():960274. PubMed ID: 36176459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyper response to ovarian stimulation affects the follicular fluid metabolomic profile of women undergoing IVF similarly to polycystic ovary syndrome.
    Cordeiro FB; Cataldi TR; de Souza BZ; Rochetti RC; Fraietta R; Labate CA; Lo Turco EG
    Metabolomics; 2018 Mar; 14(4):51. PubMed ID: 30830356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular fluid 25-hydroxyvitamin D levels determine fertility outcome in patients with polycystic ovary syndrome.
    Ozyurt R; Karakus C
    Taiwan J Obstet Gynecol; 2022 Jul; 61(4):620-625. PubMed ID: 35779910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive value of anti-Mullerian hormone levels in serum and follicle fluid for IVF-ET outcomes in patients with polycystic ovarian syndrome].
    Chen X; Yin M; Ye D; He Y; Chen S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):546-9. PubMed ID: 23644117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic alterations associated with polycystic ovary syndrome: A UPLC Q-Exactive based metabolomic study.
    Chen X; Lu T; Wang X; Sun X; Zhang J; Zhou K; Ji X; Sun R; Wang X; Chen M; Ling X
    Clin Chim Acta; 2020 Mar; 502():280-286. PubMed ID: 31758934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry.
    Sun Z; Chang HM; Wang A; Song J; Zhang X; Guo J; Leung PCK; Lian F
    Reprod Biol Endocrinol; 2019 Jun; 17(1):45. PubMed ID: 31186025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR metabolic profiling of follicular fluid for investigating the different causes of female infertility: a pilot study.
    Castiglione Morelli MA; Iuliano A; Schettini SCA; Petruzzi D; Ferri A; Colucci P; Viggiani L; Cuviello F; Ostuni A
    Metabolomics; 2019 Jan; 15(2):19. PubMed ID: 30830455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High coverage of targeted lipidomics revealed lipid changes in the follicular fluid of patients with insulin-resistant polycystic ovary syndrome and a positive correlation between plasmalogens and oocyte quality.
    Zhang M; Wang Y; Di J; Zhang X; Liu Y; Zhang Y; Li B; Qi S; Cao X; Liu L; Liu S; Xu F
    Front Endocrinol (Lausanne); 2024; 15():1414289. PubMed ID: 38904043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pregnancy outcomes of patients with polycystic ovary syndrome undergoing in vitro fertilization and embryo transfer].
    Yan X; Shi YH; Sheng Y; Tang R; Xu LH; Li Y; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):923-7. PubMed ID: 22333283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization.
    Niu Z; Ye Y; Xia L; Feng Y; Zhang A
    Cytokine; 2017 Mar; 91():180-186. PubMed ID: 28082237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sex hormone-binding globulin polymorphisms on the outcome of in vitro fertilization-embryo transfer for polycystic ovary syndrome patients: A case-control study.
    Liu Y; Zhao XX; Hu XJ; Yang F; Lin P; Cui SC; Zhao W; Cao XY; Wang YS
    J Cell Biochem; 2019 Mar; 120(3):4675-4686. PubMed ID: 30520140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome.
    Chen Y; Ye B; Yang X; Zheng J; Lin J; Zhao J
    J Int Med Res; 2017 Jun; 45(3):1138-1147. PubMed ID: 28449632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of Shen invigorating and Chong-channel regulating method on anti-Müllerian hormone and oocyte quality in polycystic ovarian syndrome patients].
    Lian F; Zhao S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jan; 32(1):9-12. PubMed ID: 22500381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profile of follicular fluid from patients with polycystic ovary syndrome (PCOS) submitted to in vitro fertilization (IVF) compared to oocyte donors.
    Domingues TS; Bonetti TC; Pimenta DC; Mariano DOC; Barros B; Aquino AP; Motta ELA
    JBRA Assist Reprod; 2019 Oct; 23(4):367-391. PubMed ID: 31173497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
    Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
    Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.